We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Bill Would End Conflict-of-Interest Waivers for FDA Advisers
House Bill Would End Conflict-of-Interest Waivers for FDA Advisers
June 10, 2005
The FDA’s use of conflict-of-interest waivers for members of its advisory committees would end under an amendment passed narrowly June 8 by the full House.